PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Infectious Disease Unit, Department of System Medicine, Tor Vergata University and Hospital, Rome, Italy.\', \'Multiple Sclerosis Clinical and Research Unit, Department of Systems Medicine, Tor Vergata University and Hospital, Rome, Italy.\', \'Department of Biomedicine and Prevention, Tor Vergata University and Hospital, Rome, Italy.\', \'Department of Experimental Medicine, Tor Vergata University and Hospital, Rome, Italy.\', \'Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.\', \'Department of Infectious Diseases, Istituto Superiore di Sanità (ISS), Roma, Italy.\', \'Unit of Neurology, IRCCS Istituto Neurologico Mediterraneo NEUROMED, Pozzilli, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.3389/fimmu.2021.796482
?:doi
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 35111162
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
is ?:relation_isRelatedTo_publication of
?:title
  • B- and T-Cell Responses After SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Receiving Disease Modifying Therapies: Immunological Patterns and Clinical Implications.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35111162>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35111162>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all